Agilent Technologies, Inc. (NYSE:A) Position Reduced by US Bancorp DE

US Bancorp DE reduced its position in shares of Agilent Technologies, Inc. (NYSE:A) by 0.8% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 65,409 shares of the medical research company’s stock after selling 527 shares during the quarter. US Bancorp DE’s holdings in Agilent Technologies were worth $9,712,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of A. Crewe Advisors LLC raised its holdings in shares of Agilent Technologies by 114.8% in the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Livelsberger Financial Advisory acquired a new position in Agilent Technologies in the third quarter worth approximately $28,000. Ridgewood Investments LLC bought a new position in shares of Agilent Technologies in the second quarter valued at $29,000. Fortitude Family Office LLC lifted its position in shares of Agilent Technologies by 68.3% during the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 95 shares during the last quarter. Finally, Ashton Thomas Private Wealth LLC bought a new stake in shares of Agilent Technologies during the 2nd quarter worth $39,000. Institutional investors own 87.42% of the company’s stock.

Agilent Technologies Trading Up 5.0 %

Shares of NYSE A opened at $136.87 on Friday. The business has a 50 day simple moving average of $139.73 and a 200 day simple moving average of $138.05. Agilent Technologies, Inc. has a 52 week low of $102.70 and a 52 week high of $155.35. The stock has a market cap of $39.33 billion, a price-to-earnings ratio of 28.40, a PEG ratio of 6.31 and a beta of 1.07. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the firm posted $1.43 earnings per share. The company’s revenue for the quarter was down 5.6% compared to the same quarter last year. On average, research analysts predict that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st were given a $0.236 dividend. The ex-dividend date was Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.69%. Agilent Technologies’s dividend payout ratio is currently 19.50%.

Analyst Ratings Changes

Several equities research analysts have recently commented on A shares. Wells Fargo & Company started coverage on Agilent Technologies in a report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 target price for the company. Bank of America raised their target price on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Evercore ISI boosted their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. Barclays raised their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “underweight” rating in a research note on Tuesday, October 15th. Finally, Stifel Nicolaus reissued a “buy” rating and set a $151.00 target price on shares of Agilent Technologies in a research note on Monday, August 26th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $144.36.

Insider Transactions at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the sale, the chief executive officer now directly owns 24,118 shares in the company, valued at approximately $3,497,110. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the transaction, the chief executive officer now owns 24,118 shares of the company’s stock, valued at $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the sale, the senior vice president now owns 40,011 shares of the company’s stock, valued at $5,801,595. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 11,995 shares of company stock worth $1,739,510. 0.33% of the stock is owned by corporate insiders.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.